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A well designed controlled drug delivery system can overcome some of the problems of conventional therapy and 
enhance the therapeutic efficacy of a given drug. To obtain maximum therapeutic efficacy, it becomes necessary to deliver 
the agent to the target tissue in the optimal amount in the right period of time there by causing little toxicity and minimal 
side effects. There are various approaches in delivering a therapeutic substance to the target site in a sustained controlled 
release fashion. One such approach is using microspheres as carriers for drugs. In this article importance of microsphere as 
a novel drug delivery carrier to attain site specific drug delivery was discussed.  
Keywords: polymer, SEM, Entrapment efficiency. 
1. Introduction  
Microspheres are characteristically free flowing 
powders consisting of protein or synthetic polymers which 
are biodegradable in nature and ideally having a particle 
size less than 200 µm[1,2]. In contrast to drug delivery 
system, the word novel is searching something out of 
necessity. The drug has to be delivered for a prolonged 
period of time and many medicines have to be taken 
simultaneously in case of chronic patients. Frequent 
administration of drug is necessary when those have shorter 
half-life and all these leads to decrease in patient’s 
compliance [3]. In order to overcome the above problems, 
various types of controlled release dosage forms are 
formulated and altered, so that patient compliance increase 
through prolonged effect, adverse effect decreases by 
lowering peak plasma concentration[4]. The controlled 
release dosage form maintaining relatively constant drug 
level in the plasma by releasing the drug at a predetermined 
rate for an extended period of time. 
One such in Microspheres as carriers of drug 
become an approach of controlled release dosage form in 
novel drug delivery system. Microspheres are defined as 
“Monolithic sphere or therapeutic agent distributed 
throughout the matrix either as a molecular dispersion of 
particles” (or) can be defined as structure made up of 
continuous phase of one or more miscible polymers in 
which drug particles are dispersed at the molecular or 
macroscopic level. It has a particle size of (1-1000nm)[5]. 
 
2. Advantages of microspheres [6]
 
 Increase bioavailability  
 Alter the drug release & separation of reactive core from 
other materials. 
 Improve the patient’s compliance  
 Reliable means to deliver the drug to the target site with 
specificity, if modified, and to maintain the desired 
concentration at the site of interest without untoward 
effects. 
 Reduce the reactivity of the core in relation to the outside 
environment. 
 The size, surface charge and surface hydrophilicity of 
microspheres have been found to be important in 
determining the fate of particles in vivo.  
 Decrease evaporation rate of the volatile core material. 
 Convert liquid to solid form & to mask the bitter taste.  
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 Protects the GIT from irritant effects of the drug. 
 Biodegradable microspheres have the advantage over 
large polymer implants in that they do not require 
surgical procedures for implantation and removal.  
 Controlled release delivery biodegradable microspheres 
are used to control drug release rates thereby decreasing 
toxic side effects, and eliminating the inconvenience of 
repeated injections [7,8].  
 
3. Classification of polymers  
Microspheres used usually are polymers. They are 
classified into two types [9]- 
3.1 Synthetic polymers:  
It is divided into two types 
a. Non-biodegradable polymers 
e.g. Poly methyl methacrylate (PMMA), Acrolein, Glycidyl 
methacrylate, Epoxy polymers.  
b. Biodegradable polymers 
e.g. Lactides, Glycolides & their co polymers, Poly alkyl 
cyano acrylates, Poly anhydrides. 
3.2 Natural polymers: 
It is obtained from different sources like proteins, 
carbohydrates and chemically modified carbohydrates. 
Proteins: Albumin, Gelatin, and Collagen. 
Carbohydrates: Agarose, Carrageenan, Chitosan, Starch. 
Chemically modified carbohydrates: Poly dextran, Poly 
starch. 
 
4. Types of Microspheres 
4.1. Bio-adhesive microspheres [10]
 
Adhesion can be defined as sticking of drug to the 
membrane by using the sticking property of the water 
soluble polymers. Adhesion of drug delivery device to the 
mucosal membrane such as buccal, ocular, rectal, nasal etc 
can be termed as bio adhesion. These kinds of microspheres 
exhibit a prolonged residence time at the site of application 
and causes intimate contact with the absorption site and 
produces better therapeutic action.  
4.2. Magnetic microspheres [11]
 
This kind of delivery system is very much 
important which localizes the drug to the disease site. In 
this larger amount of freely circulating drug can be replaced 
by smaller amount of magnetically targeted drug. Magnetic 
carriers like chitosan, dextran etc receive magnetic 
responses to a magnetic field from incorporated materials.  
A. Therapeutic magnetic microspheres 
They are used to deliver chemotherapeutic agent to 
liver tumour. Drugs like proteins and peptides can also be 
targeted through this system. 
B. Diagnostic microspheres  
It can be used for imaging liver metastases and 
also can be used to distinguish bowel loops from other 
abdominal structures by forming nano size particles supra 
magnetic iron oxides.  
4.3. Floating microspheres [12]
 
In floating types the bulk density is less than the 
gastric fluid and so remains buoyant in stomach without 
affecting gastric emptying rate. The drug is released slowly 
at the desired rate, if the system is floating on gastric 
content increases gastric residence and causes fluctuation in 
plasma concentration. Moreover it also reduces chances of 
striking and dose dumping. One another way it produces 
prolonged therapeutic effect and therefore reduces dosing 
frequencies. Drug (ketoprofen) given through this form. 
4.4. Radioactive microspheres [13]
 
Radio emobilisation therapy microspheres sized 
10-30 nm are of larger than capillaries and gets tapped in 
first capillary bed when they come across. They are injected 
to the arteries that lead to tumour of interest. So all these 
conditions radioactive microspheres deliver high radiation 
dose to the targeted areas without damaging the normal 
surrounding tissues. It differs from drug delivery system, as 
radio activity is not released from microspheres but acts 
from within a radioisotope typical distance and the different 




The different types of polymeric microspheres can 
be classified as follows and they are biodegradable 
polymeric microspheres and Synthetic polymeric 
microspheres. 
A. Biodegradable polymeric microspheres [14]
 
The natural polymers such as starch are used with 
the concept that they are biodegradable, biocompatible, and 
also bio adhesive in nature. Biodegradable polymers 
prolongs the residence time when contact with mucous 
membrane due to its high degree of swelling property with 
aqueous medium, results gel formation. The rate and extent 
of drug release is controlled by concentration of polymer 
and the release pattern in a sustained manner. The main 
drawback is, in clinical use drug loading efficiency of 
biodegradable microspheres is complex and is difficult to 
control the drug release. However they provide wide range 
of application in microsphere based treatment. 
B. Synthetic polymeric microspheres [15]
 
The interest of synthetic polymeric microspheres 
are widely used in clinical application. 
Moreover that also used as bulking agent, fillers, 
embolic particles, drug delivery vehicles etc and proved to 
be safe and biocompatible. But the main disadvantage of 
these kinds of microspheres, are tend to migrate away from 
injection site and lead to potential risk, embolism and 
further organ damage. 
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5. Techniques used in the preparation of 
microspheres  
The choice of the technique mainly depends on the 
nature of the polymer used, the drug, the equivocally 
determined by some formulation and technology related 
factors as mentioned below 
 The particle size requirement: 
a) The drug or the protein should not be adversely 
affected by the process. 
b) Reproducibility of the release profile and the method. 
c) No stability problem. 
d) There should be no toxic product(s) associated with the 
final product[16] 
Different types of techniques are employed for the 
preparation of the microspheres using hydrophobic and 
hydrophilic polymers as matrix materials are,  
5.1. Single emulsion technique [17,18]
 
The micro particulate carriers of natural polymers 
i.e. those of proteins and carbohydrates are prepared by 
single emulsion technique. The natural polymers are 
dissolved or dispersed in aqueous medium followed by 
dispersion in non-aqueous medium like oil. Next cross 
linking of the dispersed globule is carried out. The cross 
linking can be achieved either by means of heat or by using 
the chemical cross linkers. The chemical cross linking 
agents used are glutaraldehyde, formaldehyde, di acid 
chloride etc. Heat denaturation is not suitable for 
thermolabile substances. Chemical cross linking suffers the 
disadvantage of excessive exposure of active ingredient to 
chemicals if added at the time of preparation and then 
subjected to centrifugation, washing, separation. 
5.2. Double emulsion technique (Multiple emulsions)  
Double emulsion method of microsphere 
preparation involves the formation of the multiple 
emulsions or the double emulsion of type w/o/w .and is best 
suited to the water-soluble drugs, peptides, proteins and the 
vaccines. This method can be used with both the natural as 
well as the synthetic polymers. A number of hydrophilic 
drugs like leutinizing hormone releasing hormone (LH-RH) 
agonist, vaccines, protein/peptides and conventional 
molecules are successfully incorporated in to the 
microspheres using the method of double emulsion solvent 
evaporation/extraction. 
5.3. Polymerization techniques  
The polymerization techniques conventionally 
used for the preparation of the microspheres are mainly 
classified as: I. Normal polymerization 
     II. Interfacial polymerization. 
Both are carried out in liquid phase.   
Normal polymerization is carried out using 
different techniques as bulk, suspension, precipitation, 
emulsion and micellar polymerization processes. 
In Bulk polymerization, a monomer or a mixture 
of monomers along with the initiator or catalyst is usually 
heated to initiate polymerization. Polymer so obtained may 
be moulded as microspheres. Drug loading may be done 
during the process of polymerization. 
Suspension polymerization also referred as bead 
or pearl polymerization. Here it is carried out by heating the 
monomer or mixture of monomers as droplets dispersion in 
a continuous aqueous phase. The droplets may also contain 
an initiator and other additives. 
Emulsion polymerization differs from suspension 
polymerization as due to the presence initiator in the 
aqueous phase, which later on diffuses to the surface of 
micelles.  
Bulk polymerization has an advantage of 
formation of pure polymers, but it is very difficult to 
dissipate the heat of reaction, which can adversely affect the 
thermo labile active ingredients. On the other hand the 
suspension and emulsion polymerization can be carried out 
at lower temperature. 
Interfacial polymerization 
Interfacial polymerization essentially precedes 
involving reaction of various monomers at the interface 
between the two immiscible liquid phases to form a film of 
polymer that essentially envelops the dispersed phase. The 
monomers present in either phase diffuse rapidly and 
polymerize rapidly at the interface. Monomer droplet, the 
formed carrier is of capsular (reservoir) type. The 
interfacial polymerization is not widely used in the 
preparation of the microspheres because of toxicity 
associated with the unreacted monomer, high permeability 
of the film, high degradation of the drug during the 
polymerization, fragility of microcapsules, non-
biodegradability of the microspheres. 
5.4. Phase separation coacervation technique 
The process is based on the principle of decreasing 
the solubility of the polymer in the organic phase to affect 
the formation of the polymer rich phase called coacervates. 
The coacervation can be brought about by addition of the 
third component to the system which results on the 
formation of the two phases, one rich in the polymer while 
the other one, i.e. supernatant, depleted of the polymer. The 
methods are based on salt addition, non-solvent additi0on, 
addition of the incompatible polymer or change in pH. 
5.5. Spray drying  
These methods are based on the drying of the mist 
of the polymer and drug in the air. Depending upon the 
removal of the solvent or cooling of the solution, the two 
processes are named spray drying and spray congealing 
respectively. The polymer is first dissolved in a suitable 
volatile organic solvent such as dichloromethane, acetone, 
etc. The drug in the solid form is then dispersed in the 
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polymer solution under high- speed homogenization. This 
dispersion is then atomized in a stream of hot air. The 
atomization leads to the formation of the small droplets or 
the fine mist from which the solvent evaporates 
instantaneously leading the formation of the microspheres 
in a size range 1-100 µm. Microspheres are separated from 
the hot air by means of the cyclone separator while the 
traces of solvent are removed by vacuum drying. One of the 
major advantages of the process is feasibility of operation 
under aseptic conditions. The spray drying process is used 
to encapsulate various penicillin’s. Thiamine mononitrate 
and sulpha ethylthiadizole are encapsulated in a mixture of 
mono- and diglycerides of stearic acid and palmitic acid 
using spray congealing. Very rapid solvent evaporation, 
however leads to the formation of porous microspheres. 
5.6. Non-aqueous solvent evaporation method  
In these methods the polymer is dissolved in an 
organic solvent such as dichloromethane, chloroform, 
alcohol or ethyl acetate, either alone or in combination. The 
drug is either dissolved or dispersed into the polymer 
solution and this solution containing the drug is emulsified 
in to an aqueous phase to make oil in water emulsion by 
using a surfactant or an emulsifying agent. After the 
formation of a stable emulsion, the organic solvent is 
evaporated either by increasing the temperature or by 
continuous stirring. Solvent evaporation for preparation of 
embryonic microspheres under pressure or by continuous 
stirring, determines the size and morphology of the 
microspheres. It had been reported that the rapid removal of 
the solvent from the embryonic microspheres leads to the 
precipitation at the o/w interface. This leads to the 
formulation of cavity in the microspheres, making them 
hollow 
5.7. Ionic gelation method: 
 Ionotropic gelation is based on the ability of 
polyelectrolytes to cross link in the presence of counter ions 
to form hydrogels. These anions forms meshwork structure 
by combining with the polyvalent cations and induce 
gelation by binding mainly to the anion blocks. The 
hydrogel beads are produced by dropping a drug-loaded 
polymeric solution into the aqueous solution of polyvalent 
cations. The cations diffuses into the drug-loaded polymeric 
drops, forming a three dimensional lattice of ionically 
crossed linked moiety. 
 
6. Applications 
6.1 Microspheres in vaccine delivery  
The prerequisite of a vaccine is protection against 
the microorganism or its toxic product. An ideal vaccine 
must fulfill the requirement of efficacy, safety, 
convenience in application and cost. The aspect of safety 
and minimization of adverse reaction is a complex issue 
[19]. The aspect of safety and the degree of the production 
of antibody responses are closely related to mode of 
application. Biodegradable delivery systems for vaccines 
that are given by parenteral route may overcome the 
shortcoming of the conventional vaccines [20]. The interest 
in parenteral (subcutaneous, intramuscular, intradermal) 
carrier lies since they offer specific advantages including: 
 Improved antigenicity by adjuvant action 
 Modulation of antigen release 
  Stabilization of antigen.  
 Targeting using micro particulate carriers  
The concept of targeting, i.e. site specific drug 
delivery is a well-established dogma, which is gaining full 
attention. The therapeutic efficacy of the drug relies on its 
access and specific interaction with its candidate receptors. 
The ability to leave the pool in reproducible, efficient and 
specific manner is center to drug action mediated by use of 
a carrier system. Placement of the particles indiscrete 
anatomical compartment leads to their retention either 
because of the physical properties of the environment or 
biophysical interaction of the particles with the cellular 
content of the target tissue. 
6.2. Chemoembolisation 
Chemoembolisation is an endovascular therapy, 
which involves the selective arterial embolisation of a 
tumour together with simultaneous or subsequent local 
delivery of the chemotherapeutic agent. The theoretical 
advantage is that such embolisations will not only provide 
vascular occlusion but will bring about sustained 
therapeutic levels of chemotherapeutics in the areas of the 
tumour. Chemoembolisation is an extension of traditional 
percutaneous embolisation techniques. 
6.3 Surface modified microspheres  
Different approaches have been utilized to change 
the surface properties of carriers to protect them against 
phagocytic clearance and to alter their body distribution 
patterns .The adsorption of the poloxamer on the surface of 
the polystyrene, polyester or poly methyl methacrylate 
microspheres renders them more hydrophilic and hence 
decrease their MPS uptake. Protein microspheres covalently 
modified by PEG derivatives show decreased 
immunogenicity and clearance. The most studied surface 
modifiers are: 
1. Antibodies and their fragments 
2. Proteins  
3. Mono-, oligo- and polysaccharides 
4. Chelating compounds (EDTA, DTPA or 
Desferroxamine)  
5. Synthetic soluble polymers such modifications are 
provided on surface of microspheres in order to achieve the 
targeting to the discrete organs and to avoid rapid clearance 
from the body. 
A. Krishna Sailaja and Anusha K / Review on microspheres as a drug delivery carrier                                                        100 
IJAP (2017) 06 (05)                                                                                                                                          www.ssjournals.com 
6.4 Monoclonal antibodies mediated microspheres  
Monoclonal antibodies are extremely specific 
molecules. This extreme specificity of monoclonal 
antibodies (Mabs) can be utilized to target microspheres 
loaded bioactive molecules to selected sites. Mabs can be 
directly attached to the microspheres by means of covalent 
coupling. The free aldehyde groups, amino groups or 
hydroxyl groups on the surface of the microspheres can be 
linked to the antibodies. The Mabs can be attached to 
microspheres by any of the following methods. 
1. Nonspecific adsorption 2. Specific adsorption 3. Direct 
coupling 4. Coupling via reagents 
6.5 Imaging  
The microspheres have been extensively studied 
and used for the targeting purposes. Various cells, cell lines, 
tissues and organs can be imaged using radio labelled 
microsphere. The particle size range of microspheres is an 
important factor in determining the imaging of particular 
sites. The particles injected, intravenously apart from the 
portal vein will become entrapped in the capillary bed of 
the lungs. This phenomenon is exploited for the 
scintiographic imaging of the tumour masses in lungs using 
labeled human serum albumin microspheres. 
6.6 Topical porous microspheres 
Microsponges are porous microspheres having 
myriad of interconnected voids of particle size range 5-300 
µm. These micro sponges having capacity to entrap wide 
range of active ingredients such as emollients, fragrances, 
essential oils etc. These porous microspheres with active 
ingredients can be incorporated into formulations such as 
creams, lotions and powders. Microsponges consist of non-
collapsible structures with porous surface through which 
active ingredients are released in a controlled manner [21].
 
6.7 Mcrospheres in Gene delivery [22]:
 
Gene delivery systems include viral vectors, 
cationic liposomes, polycation complexes, and 
microencapsulated systems. Viral vectors are advantageous 
for gene delivery because they are highly efficient and have 
a wide range of cell targets. However, when used in vivo 
they cause immune responses and oncogenic effects. To 
overcome the limitations of viral vectors, non-viral delivery 
systems are considered for gene therapy. Non-viral delivery 
system has advantages such as ease of preparation, 
cell/tissue targeting, low immune response, unrestricted 
plasmid size, and large-scale reproducible production. 
Polymer has been used as a carrier of DNA for gene 
delivery applications.
 
6.8. Microspheres for Oral drug delivery [23]
 
The potential of polymer films containing 
diazepam as an oral drug delivery was investigated in 
rabbits. The results indicated that a film composed of a 
1:0.5 drug-polymer mixture might be an effective dosage 
form that is equivalent to the commercial tablet dosage 
forms. The ability of polymer to form films may permit its 
use in the formulation of film dosage forms, as an 
alternative to pharmaceutical tablets. The pH sensitivity, 
coupled with the reactivity of the primary amine groups, 
make polymer a unique polymer for oral drug delivery 
applications. 
6.9. Microspheres for DNA delivery [24]: 
Microspheres have been recently used as a 
delivery vehicle for the transfer of plasmid DNA which 
leads to improve the transfer of plasmid DNA and their 
stability in the bio- environment. Truong-Le & Coworkers 
(1998) developed a novel system for gene delivery based on 
the use of DNA-gelatin microspheres/ nanoparticles formed 
by salt induced complex coacervation of gelatin & plasmid 
DNA.  
6.10 Recent Applications of Controlled Release 
Microspheres   
Controlled-release microspheres are in 
development for a number of interesting and important 
applications, especially for delivery of large, fragile drugs 
like proteins and nucleic acids. Several recent examples are 
described below. Controlled-Release Vaccines Vaccination 
has been highly successful for controlling or even 
eradicating many important types of infectious diseases, 
and new or improved vaccines are being heavily 
investigated for AIDS, hepatitis B, anthrax, and SARS.A 
frequent problem is the need for repeated administrations. 
Single-shot Vaccine delivery systems should provide the 
antigen(s) and adjuvant on a prescribed schedule and 
maintain the bioactivity of the antigen, both during 
fabrication of the delivery device and during the often 
prolonged residence time of the device in the body. To 
enhance vaccine stability, researchers have been focusing 
on several approaches, including the use of adjuvants to 
protect the protein antigens or by choosing different 
microsphere materials. A major advantage of microspheres 
for vaccination is that they can be passively targeted to 
antigen-presenting cells (APCs) such as macrophages and 
dendritic cells. The ability of APCs to phagocytose 
particulates is dependent on the particle size. In particular, 
1- to 10-µm diameter microspheres are optimally taken up 
by APCs in a number of tissues and have been shown to 
enhance antigen-specific T-helper lymphocyte (Th) 
responses thus leading to an enhancement in antigen-
specific antibody responses) and elicit a cytotoxic T 
lymphocyte (CTL) response T-cell activation in response to 
antigen encapsulating microspheres has been shown to be 
100-1000 fold better than antigen alone. 
6.11 Stabilization of Encapsulated Protein Therapeutics 
A major problem with protein encapsulation in 
polymer particles is loss of protein bioactivity. Damage to 
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proteins can occur during fabrication of the particles via 
shear stresses or other physical forces, through contact with 
organic solvents, and by loss of water (e.g., upon 
lyophilization) as well as during incubation and release in 
the warm, moist, in vivo environment. 
Two types of damage occur most often:  
(i) Covalent or non-covalent intermolecular aggregation and 
(ii) Denaturation. Several studies have investigated the 
mechanisms of damage. Protein stability can be enhanced 
by the addition of excipients to prevent aggregation and 
stabilize the folded protein structure or through judicious 
choice of polymer employed for fabrication of the devices. 
 
7. Future Challenges 
Future challenges of microspheres look bright 
particularly in the area of medicinal field because of its 
wide spectrum of application in molecular biology, e.g.: 
microsphere based genotyping platform is used to detect six 
single nucleotide polymorphism, yittrium-90 microspheres 
are used to prevent tumour after liver transplantation and 
it’s advanced way in delivery of vaccines and proteins. 
7.1 Microspheres in cancer therapy 
Cancer microsphere technology is the latest trend 
in cancer therapy. It helps the pharmacist to formulate the 
product with maximum therapeutic value and minimum or 
negligible range side effects. Cancer is a disease in which 
the abnormal cells are quite similar to the normal cells, with 
just minute genetic or functional change. A major 
disadvantage of anticancer drugs is their lack of selectivity 
for tumor tissue alone, which causes severe side effects and 
results in low cure rates. Thus, it is very difficult to target 
abnormal cells by the conventional method of the drug 
delivery system. Microsphere technology is probably the 
only method that can be used for site-specific action, 
without causing significant side effects on normal cells.  
 
Table 1: Marketed products of microspheres 
Drug Commercial Name Company Technology Indication 
Risperidone RESPERDAR,CONSTAR Jansenn/Alkermes,inc. Double emulsion(oil in water) Schizophrenia; Bipolar 
Disorder 
Naltrexone VIVITROLR Alkermes Double emulsion(oil in water) Alcohol dependence 
Octreotide Sandostatin LAR Novartis Phase separation Acromegaly 
Somatropin NutropinR Depot-a Genentech /alkermes  Alkermes proleaseR Technology 
(cryogenic spray drying method) 
Growth deficiencies  
Bromocriptine Parlodel LAR Novartis Spray drying Parkinsonism 
Minocycline Arestin  Orapharma   Periodontitis 
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